Intellia Therapeutics Inc.

In News

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Intellia Therapeutics

Intellia Therapeutics - Jan 07, 2026

Intellia Therapeutics, Inc. Updates on Clinical Trials and Regulatory Plans - TradingView — Track All Markets

TradingView — Track All Markets - Jan 09, 2026

Gene editing firm Intellia to share CRISPR work at major health event - Stock Titan

Stock Titan - Jan 07, 2026

Intellia Therapeutics: Critical Safety Updates Are Imminent - Expect Volatility (NTLA) - Seeking Alpha

Seeking Alpha - Dec 02, 2025

Insider Buying: Fred Cohen Acquires 150,000 Shares of Intellia Therapeutics Inc (NTLA) - GuruFocus

GuruFocus - Jan 07, 2026

44th Annual J.P. Morgan Healthcare Conference - Intellia Therapeutics

Intellia Therapeutics - Jan 07, 2026

Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory - Yahoo Finance

Yahoo Finance - Dec 04, 2025

Why Intellia Therapeutics (NTLA) Is Down After FDA Halts Key CRISPR Trial Over Safety Concerns – And What's Next - Sahm

Sahm - Jan 07, 2026

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates - Intellia Therapeutics

Intellia Therapeutics - Nov 06, 2025

Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress - Yahoo Finance

Yahoo Finance - Nov 25, 2025

Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z) - Intellia Therapeutics

Intellia Therapeutics - Oct 27, 2025

Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress - Intellia Therapeutics

Intellia Therapeutics - Aug 07, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment